Skip to main content
Equibles

SCHRODER INVESTMENT MANAGEMENT GROUP

Position in ADCT — ADC Therapeutics SA

CIK 1086619 London, X0
Back to ADCT Full portfolio

Position in ADCT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$448,096
-$1,122,336 QoQ
Shares Held
418,782
0.0% QoQ
Ownership
0.328%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 113 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADCT Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

SCHRODER INVESTMENT MANAGEMENT GROUP holds $225,719,959 across 11 Drug Manufacturers - Specialty & Generic names. ADCT ranks #11 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TEVA
Teva Pharmaceutical Industries Ltd
 2,280,484 $77,262,797
2 UTHR
UNITED THERAPEUTICS Corp
 72,306 $39,177,559
3 HIMS
Hims & Hers Health, Inc.
 1,129,781 $39,169,506
4 RDY
Dr Reddys Laboratories Ltd
 1,618,404 $23,450,672
5 SUPN
Supernus Pharmaceuticals, Inc.
 368,017 $17,116,470
6 HCM
HUTCHMED (China) Ltd
 1,477,494 $15,897,835
7 ELAN
Elanco Animal Health Inc
 333,656 $8,211,273
8 NBIX
Neurocrine Biosciences Inc
 16,253 $2,739,280

All Filings in ADCT

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $448,096 418,782
2026-03-31 $1,570,432 418,782
2025-12-31 $1,478,300 418,782